Citadel Advisors’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Sell |
|
|||||
|
2025
Q1 | $2.36M | Buy |
|
|||||
|
2024
Q4 | $114K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.56M | Buy |
|
|||||
|
2024
Q1 | $2.34M | Sell |
|
|||||
|
2023
Q4 | $7.5M | Sell |
|
|||||
|
2023
Q3 | $17.6M | Buy |
|
|||||
|
2023
Q2 | $203K | Sell |
|
|||||
|
2023
Q1 | $7.29M | Buy |
|
|||||
|
2022
Q4 | $7.1M | Sell |
|
|||||
|
2022
Q3 | $46.6M | Buy |
|
|||||
|
2022
Q2 | $3.87M | Sell |
|
|||||
|
2022
Q1 | $15.3M | Buy |
|
|||||
|
2021
Q4 | $10.4M | Sell |
|
|||||
|
2021
Q3 | $64.7M | Buy |
|
|||||
|
2021
Q2 | $27.6M | Buy |
|
|||||
|
2021
Q1 | $11.4M | Sell |
|
|||||
|
2020
Q4 | $32.9M | Buy |
|